Drugmakers from Merck to Pfizer slid on Tuesday after investors see House leader Nancy Pelosi’s "scary" and "aggressive" drug pricing plan

Drugmakers from Merck to Pfizer slid on Tuesday after investors see House leader Nancy Pelosi’s "scary" and "aggressive" drug pricing plan https://t.co/g2dxTBp0tx pic.twitter.com/troiUCnueT

— Bloomberg Markets (@markets) September 10, 2019